A61K 40/429
Small organic molecules e.g. cocaine or nicotine
Official title: {Small organic molecules e.g. cocaine or nicotine}
A61K40/429 (Small organic molecules e.g. cocaine or nicotine) appears on 8 US grants and 32 published applications in this corpus.
Search patents in A61K- Granted patents
- 8
- Published applications
- 32
- Assignees
- 26
- Inventors
- 96
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 2 |
| 2022 | 1 | 2 |
| 2023 | 2 | 6 |
| 2024 | 0 | 6 |
| 2025 | 2 | 4 |
| 2026 | 2 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- mRNA construct for protein expression and use of same26 May 2026US 12,637,689 B2Korea Research Institute of Bioscience and Biotechnology
- Anti-dinitrophenol chimeric antigen receptors10 Mar 2026US 12,570,716 B2Seattle Children's Hospital
- Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereof2 Dec 2025US 12,485,185 B2Seoul National University R&Db Foundation
- Sequencing method for CAR T cell therapy4 Mar 2025US 12,240,870 B2Endocyte, Inc.
- Compositions and methods for CAR T cell therapy26 Dec 2023US 11,850,262 B2Endocyte, Inc.
- Compositions and methods for targeting solid tumors with chimeric antigen receptor (car) macrophages17 Sep 2026US 2026/0273056 A1Rutgers, The State University of New Jersey
- Therapeutic methods with target-linked small molecules and anti-target car t cells10 Sep 2026US 2026/0263517 A1Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Synthetic antigen receptors for covalent immune recruiters and methods and uses thereof27 Aug 2026US 2026/0248852 A1McMaster University
- Bi-specific adapters and their use with universal car-t cells in the treatment of tumors and the inhibition of cancer-associated fibroblasts27 Aug 2026US 2026/0248923 A1Purdue Research Foundation
- Multivalent Chlorotoxin Chimeric Antigen Receptors19 Mar 2026US 2026/0078529 A1IN8bio, Inc.
Most cited
By later US patents
- Compositions and methods for CAR T cell therapy5US 11,759,480 B2Endocyte, Inc. · 2023
- Compositions and methods for CAR T cell therapy4US 11,850,262 B2Endocyte, Inc. · 2023
- Bromodomain inhibitor as adjuvant in cancer immunotherapy1US 10,813,939 B2Dana-Farber Cancer Institute, Inc. · 2020
- Sequencing method for CAR T cell therapy1US 12,240,870 B2Endocyte, Inc. · 2025